Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.451 USD | -1.95% | -8.15% | +43.68% |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.68% | 91.19M | |
+5.47% | 111B | |
+11.01% | 105B | |
-12.21% | 22.34B | |
-3.23% | 21.93B | |
-6.08% | 18.59B | |
-36.52% | 18.12B | |
-10.32% | 16.96B | |
+2.77% | 13.7B | |
+38.95% | 12.45B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Raymond James Trims Price Target on Passage Bio to $9 From $10, Keeps Outperform Rating